Proof-of-principle for two-stage photodynamic therapy: Hypoxia triggered release of singlet oxygen

51Citations
Citations of this article
41Readers
Mendeley users who have this article in their library.

Abstract

We propose to overcome oxygen deficiency and light attenuation problems in photodynamic therapy (PDT), by separating photoexcitation and singlet oxygen delivery of the PDT process into two distinct operations to be carried out sequentially, at different locations. We now demonstrate the viability of this approach, using 2-pyridone derivative which yields a relatively stable endoperoxide. The initial storage endoperoxide obtained is transformed enzymatically into a more labile compound when placed in hypoxic cell cultures, and releases singlet oxygen significantly faster. The potential of this approach in advancing PDT beyond its current limits is exciting. This journal is

Cite

CITATION STYLE

APA

Ayan, S., Gunaydin, G., Yesilgul-Mehmetcik, N., Gedik, M. E., Seven, O., & Akkaya, E. U. (2020). Proof-of-principle for two-stage photodynamic therapy: Hypoxia triggered release of singlet oxygen. Chemical Communications, 56(94), 14793–14796. https://doi.org/10.1039/d0cc06031c

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free